Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poliomyelitis Vaccines”

256 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 256 results

Testing effectiveness (Phase 2)Looking for participantsNCT06137664
What this trial is testing

Study of Trivalent and Bivalent (Types 1 & 2) Novel Oral Poliomyelitis Vaccines

Who this might be right for
Poliomyelitis
PATH 2,400
Large-scale testing (Phase 3)Study completedNCT01983540
What this trial is testing

Antibody Persistence at Age 3.5 and 4.5 Years After Primary and Booster DTaP-IPV-Hep B-PRP~T or Infanrix Hexa Vaccination

Who this might be right for
DiphtheriaTetanusWhooping Cough+3 more
Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06618196
What this trial is testing

Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age

Who this might be right for
DiphtheriaTetanusPertussis+3 more
LG Chem 336
Early research (Phase 1)Study completedNCT01048190
What this trial is testing

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains

Who this might be right for
Poliomyelitis
Chinese Academy of Medical Sciences 130
Testing effectiveness (Phase 2)Study completedNCT04027036
What this trial is testing

Comparison of Immunogenicity of Inactivated Poliovirus Vaccine (IPV) Administered Intramuscularly or Intradermally

Who this might be right for
Polio
Instituto Nacional de Saúde, Mozambique 382
Large-scale testing (Phase 3)Study completedNCT00255047
What this trial is testing

Safety and Immune Response of Different Pediatric Combination Vaccines.

Who this might be right for
DiphtheriaPolioPertussis
Sanofi Pasteur, a Sanofi Company 2,167
Large-scale testing (Phase 3)WithdrawnNCT03128489
What this trial is testing

Evaluation of Immunogenicity and Safety of DTPa-IPV/Hib Conjugate Vaccine (Infanrix™-IPV/Hib) Administered at 6, 10 and 14 Weeks in Healthy Indian Infants

Who this might be right for
DiphtheriaAcellular PertussisHaemophilus Influenzae Type b+2 more
GlaxoSmithKline
Not applicableUnknownNCT00710983
What this trial is testing

Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth

Who this might be right for
Infant, NewbornHealthy
Bandim Health Project
Post-approval studies (Phase 4)Study completedNCT02853929
What this trial is testing

Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery

Who this might be right for
DiphtheriaHepatitis BAcellular Pertussis+4 more
GlaxoSmithKline 551
Post-approval studies (Phase 4)Study completedNCT00635128
What this trial is testing

Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

Who this might be right for
PoliomyelitisDiphtheriaTetanus+1 more
GlaxoSmithKline 415
Not applicableUnknownNCT06058429
What this trial is testing

Immunogenicity of After Primary Immunization and Booster Immunization of sIPV

Who this might be right for
Polio
Sinovac Biotech Co., Ltd 233
Testing effectiveness (Phase 2)Study completedNCT01686503
What this trial is testing

Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects

Who this might be right for
Polio Immunity
Eastern Virginia Medical School 231
Post-approval studies (Phase 4)Study completedNCT00934245
What this trial is testing

Direct and Indirect Protection by Influenza Vaccine Given to Children in India

Who this might be right for
Influenza
Wayne Sullender, M.D. 4,598
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Testing effectiveness (Phase 2)Study completedNCT00133445
What this trial is testing

Pentavalent DTaP-Hep B-IPV

Who this might be right for
DiphtheriaHepatitis BPoliomyelitis+2 more
National Institute of Allergy and Infectious Diseases (NIAID) 5
Large-scale testing (Phase 3)Study completedNCT00831753
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Infanrix®Hexa in Healthy Peruvian Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 263
Testing effectiveness (Phase 2)Looking for participantsNCT05654467
What this trial is testing

Study of a Novel Type 3 Oral Poliomyelitis Vaccine in Panama

Who this might be right for
Poliomyelitis
PATH 1,532
Large-scale testing (Phase 3)Study completedNCT01457560
What this trial is testing

Immunogenicity and Reactogenicity of DTPa-HBV-IPV/Hib Vaccine Followed by the Same Vaccine and Oral Polio Vaccine

Who this might be right for
Hepatitis BAcellular PertussisHaemophilus Influenzae Type b+3 more
GlaxoSmithKline 80
Testing effectiveness (Phase 2)Study completedNCT00885157
What this trial is testing

Immunogenicity and Safety of a Fractional Booster Dose of IPV Intradermally Versus Full Dose Intramuscularly

Who this might be right for
Poliomyelitis
Sanofi Pasteur, a Sanofi Company 225
Testing effectiveness (Phase 2)Study completedNCT03566940
What this trial is testing

Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of Age Immunization Schedule

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 302
Load More Results